BGM Group Ltd.
NASDAQ · us_market
No AI summary generated yet for this ticker.
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, an ingredient for medical preparation companies to produce compound licorice oral solutions. In addition, it offers traditional Chinese medicine derivatives products comprising Ahan antibacterial paste that is used to treat refractory chronic skin diseases; heparin products, including heparin sodium preparation, an ingredient for pharmaceutical companies to produce medications used in treating cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings, such as Zhu Xiaochang sausage casings for culinary purposes. Further, the company provides Fertilizer products comprising Xiongguan organic fertilizers to improve crop yield, increase soil's chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers for plant growth. Additionally, it focuses on the AI-driven commercialization of DuXiaoBao platform. BGM Group Ltd. is based in Chengdu, China.
Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Unusual volume stocks in Tuesday's session
CHENGDU, China, Feb. 26, 2026 (GLOBE NEWSWIRE) -- BGM Group Ltd. (NASDAQ: BGM) (the “Company” or “BGM”) announced on February 24, 2026, that it has received a notification (the “Notification”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) regarding its non-compliance with the Nasdaq Listing Rule 5250 (c)(1) as a result of the Company’s failure to file its Annual Report on Form 20-F for the fiscal year ended September 30, 2025 (the “Form 20-F”) in a timely m
BGM Group Ltd. (NASDAQ: BGM) (the "Company" or "BGM") announced on February 24, 2026, that it has received a notification (the "Notification") from the Listing Qualifications Department of The Nasdaq Stock Market
In September, Seeking Alpha welcomed 21 new analysts. Check out some of their top picks here.
We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. BGM Group Ltd. is one of them. BGM Group Ltd. (NASDAQ:BGM), a China-based pharmaceutical and chemical company, is rapidly transforming into an AI- and biopharma-focused enterprise. Through subsidiaries, the company develops specialty and generic drugs while expanding into intelligent robotics […]
We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. BGM Group Ltd. is one of them. BGM Group Ltd. (NASDAQ:BGM), a China-based pharmaceutical and chemical company, is rapidly transforming into an AI- and biopharma-focused enterprise. Through subsidiaries, the company develops specialty and generic drugs while expanding into intelligent robotics […]
BGM Groupâs revenue from AI soars, profits jump 78%, yet shares remain undervalued. Read why I think BGM stock is a Buy right now and has some upside.
Qilian Intl Hldg Gr (NASDAQ:BGM) reported quarterly earnings of $0.03 per share. This is a 200 percent increase over earnings of $0.01 per share from the same period last year. The company reported $14.311 million in
BGM Group (the "Company" or "BGM") (NASDAQ: BGM) today announced that it will release its unaudited financial results for the first half 2025 before the U.S. financial markets open on July 24, 2025 Eastern Daylight Time.
Key Insights Significant insider control over BGM Group implies vested interests in company growth A total of 3...
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 46.5K | $14.08K | 0.00% | Trimmed-5.3% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-03-16 | — | — | — |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| BGM | +5.32% | -71.44% | -91.41% | -97.63% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +2.35% | -66.80% | -87.97% | -110.32% |